Insider Transactions in Q2 2023 at Cyma Bay Therapeutics, Inc. (CBAY)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2023
|
Paul T Quinlan General Counsel |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$50,000
$10.05 P/Share
|
|
Jun 30
2023
|
Paul T Quinlan General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$10,000
$2.94 P/Share
|
|
Jun 20
2023
|
Charles Mc Wherter President of R&D |
SELL
Open market or private sale
|
Direct |
21,749
-59.18%
|
$173,992
$8.16 P/Share
|
|
Jun 20
2023
|
Charles Mc Wherter President of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
21,749
+37.18%
|
$108,745
$5.0 P/Share
|
|
May 18
2023
|
Charles Mc Wherter President of R&D |
SELL
Open market or private sale
|
Direct |
21,749
-59.18%
|
$195,741
$9.08 P/Share
|
|
May 18
2023
|
Charles Mc Wherter President of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
21,749
+37.18%
|
$108,745
$5.0 P/Share
|
|
May 15
2023
|
Paul T Quinlan General Counsel |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$50,000
$10.37 P/Share
|
|
May 15
2023
|
Paul T Quinlan General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$10,000
$2.94 P/Share
|
|
Apr 17
2023
|
Dennis D Kim Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
112,219
-84.87%
|
$1,009,971
$9.54 P/Share
|
|
Apr 17
2023
|
Dennis D Kim Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
112,219
+45.91%
|
$448,876
$4.37 P/Share
|
|
Apr 13
2023
|
Dennis D Kim Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,781
-28.01%
|
$62,248
$8.98 P/Share
|
|
Apr 13
2023
|
Dennis D Kim Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,781
+21.88%
|
$31,124
$4.37 P/Share
|